Biopharma Responsible for

  • Cancer Immunotherapy
  • Immuno-Oncology
  • R&D Innovation & Strategy
  • Clinical R&D
  • Business Development
  • Preclinical and Translational Research
  • Biomarkers and Companion Dx
  • Early Stage Collaborations
  • Clinical Operations
  • Strategic Partnerships
  • External R&D
  • Licensing & Commercial Strategy


Solution Providers

  • Diagnostic Testing
  • Biomarkers and Companion Dx
  • Assay Development
  • Next Gen Sequencing
  • mRNA / DNA Nucleic Acid Processing
  • RNA Sequencing
  • Cell Analysis/Manufacturing Platforms
  • Liquid Biopsies
  • Cancer Genetics
  • Immune Monitoring
  • Imaging Services
  • Flow Cytometry
  • Data Analysis/Analytics
  • Laboratory Services
  • Artificial Intelligence
  • CROs/Clinical Trial Design

Investment Community Including

  • Investment Firms
  • Banks/Financial Institutions
  • Venture Capital
  • Private Equity
  • Foundation Capital
  • Analysts

Academia & Research Organizations Focusing on

  • Immuno-Oncology / Cancer Immunotherapy
  • Oncology
  • Immunology
  • Cancer Vaccines
  • Adoptive T-Cell Therapy
  • Preclinical & Clinical R&D
600+
Attendees
125+
Speakers
100+
Talks Over 3 Days
10+
Hours of Networking

Networking and Business Opportunities

Partnering/One-on-One Meetings

  • ​​​​​​​ Dedicated partnering tables to connect with fellow industry professionals, investors and KOLs
  • Partnering tool to schedule partnering meetings
  • Meeting times occur throughout all breaks, lunches and receptions
  • Set up multiple meetings per day
  • Search attendee profiles
  • Send private message to attendees
  • Dedicated partnering help desk

Scheduled Networking

IO360° networking opportunities take place throughout the entire event including:

  • Scheduled morning and afternoon breaks
  • Lunches
  • Reception
  • Access to the Exhibit hall